Currently Closed – We are no longer accepting or processing applications for new or renewal patients.
The PAN Foundation’s Chronic Iron or Lead Overload fund is currently closed. As of June 24, 2019, Good Days' Chronic Iron Overload fund and Healthwell's Iron Overload as a Result of Blood Transfusions fund are accepting applications.
For current information, log in to FundFinder.
$5,900 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.
- The patient must be getting treatment for chronic iron or lead overload.
- The patient must have Medicare health insurance that covers his or her qualifying medication or product.
- The patient’s medication or product must be listed on PAN’s list of covered medications.
- The patient’s income must fall at or below 500% of the Federal Poverty Level.
- The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
See the list of medications covered in this program
- Bal In Oil (dimercaprol)
- Calcium Disodium Versenate (edetate calcium disodium)
- Chemet (succimer)
- Deferasirox (deferasirox)
- Deferoxamine Mesylate (deferoxamine mesylate)
- Desferal (deferoxamine mesylate)
- Exjade (deferasirox)
- Ferriprox (deferiprone)
- Jadenu (deferasirox)
ICD-10: D56.1, D56.2, D56.3, D56.4, D56.5, D56.8, D56.9, D57.40, D57.41, D57.411, D57.412, D57.419, D57.80, D57.811, D57.812, D57.819, E83.10, E83.110, E83.111, E83.118, E83.119, E83.19
About the Disease:
Chronic iron or lead overload, also known as excess iron, hemochromatosis, iron-storage disease, iron overload, bronzed diabetes, plumbism, lead poisoning and saturnism, is a buildup of excess iron in the body. It is a chronic disease that affects the circulatory system.
Source: National Institutes of Health
About the Disease: